Daiken Medical Co., Ltd. Announces Non-Consolidated Earnings Guidance for the Six Months Ending September 30, 2021 and Full Year Ending March 31, 2022
August 03, 2021 at 02:00 am
Share
Daiken Medical Co., Ltd. announced non-Consolidated earnings guidance for the Six months ending September 30, 2021 and full year ending March 31, 2022. For the six months ending September 30, 2021, on the non-consolidated basis, the company expects, net sales of ¥4,350 million, operating profit of ¥510 million and profit of ¥360 million or ¥12.53 per share.
For the full year ending March 31, 2022, on the non-consolidated basis, the company expects, net sales of ¥9,000 million, operating profit of ¥1,200 million and profit of ¥840 million or ¥29.24 per share.
DAIKEN MEDICAL CO., LTD. is a Japan-based company mainly engaged in planning, development, manufacturing and sales of anesthesia and hospital infection control related products. The Companyâs products are divided into five groups. The suction device related products include Fit Fix suction container system and Coopdech QinPot. The syrinjector related products include syrinjector, balloonjector, patient control analgesia (PCA) devices and other pressure infusion instruments. The electric pump related products include syringe pumps and infusion pumps. The medical hand washing machine related products include SteriKeep II and Wipell. The other products include bronchial blocker tube, breath warm and others.